Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Leukemia

  Free Subscription


Articles published in Exp Cell Res

Retrieve available abstracts of 13 articles:
HTML format



Single Articles


    October 2022
  1. ZHENG D, Qiwen Zeng, He D, He Y, et al
    SIRT5 alleviates hepatic ischemia and reperfusion injury by diminishing oxidative stress and inflammation via elevating SOD1 and IDH2 expression.
    Exp Cell Res. 2022;419:113319.
    PubMed     Abstract available


    August 2022
  2. CHEN CW, Huang NK, Lee YL, Fan CK, et al
    Activin A downregulates the CD69-MT2A axis via p38MAPK to induce erythroid differentiation that sensitizes BCR-ABL-positive cells to imatinib.
    Exp Cell Res. 2022;417:113219.
    PubMed     Abstract available


    May 2022
  3. LIU H, Hussain Z, Xie Q, Yan X, et al
    Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax.
    Exp Cell Res. 2022 May 11:113192. doi: 10.1016/j.yexcr.2022.113192.
    PubMed     Abstract available


    March 2022
  4. ZHANG Y, Guo H, Zhang Z, Lu W, et al
    IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia.
    Exp Cell Res. 2022;415:113112.
    PubMed     Abstract available


    June 2021
  5. LIU Z, Zheng W, Liu Y, Zhou B, et al
    Targeting HSPA8 inhibits proliferation via downregulating BCR-ABL and enhances chemosensitivity in imatinib-resistant chronic myeloid leukemia cells.
    Exp Cell Res. 2021 Jun 19:112708. doi: 10.1016/j.yexcr.2021.112708.
    PubMed     Abstract available


    March 2021
  6. YU W, Lutz C, Kramer A, Schmidt-Zachmann MS, et al
    The JmjC-domain protein NO66/RIOX-1 affects the balance between proliferation and maturation in acute myeloid leukemia.
    Exp Cell Res. 2021 Mar 18:112566. doi: 10.1016/j.yexcr.2021.112566.
    PubMed     Abstract available


    January 2021
  7. WANG C, Li L, Li M, Shen X, et al
    Corrigendum to "Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia" [Exp. Cell Res. 398(1) 112371].
    Exp Cell Res. 2021 Jan 8:112469. doi: 10.1016/j.yexcr.2020.112469.
    PubMed    


    November 2020
  8. JAMALPOUR M, Bergquist E, Welsh M
    Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
    Exp Cell Res. 2020 Nov 18:112368. doi: 10.1016/j.yexcr.2020.112368.
    PubMed     Abstract available


  9. WANG C, Li L, Li M, Shen X, et al
    Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia.
    Exp Cell Res. 2020 Nov 11:112371. doi: 10.1016/j.yexcr.2020.112371.
    PubMed     Abstract available


    October 2020
  10. ZHAO F, Sun L, Yang N, Zheng W, et al
    Increased release of microvesicles containing mitochondria is associated with the myeloid differentiation of AML-M5 leukaemia cells.
    Exp Cell Res. 2020;395:112213.
    PubMed     Abstract available


    May 2020
  11. CHEN C, Wang L, Li L, Wang A, et al
    Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia.
    Exp Cell Res. 2020 May 3:112054. doi: 10.1016/j.yexcr.2020.112054.
    PubMed     Abstract available


    April 2020
  12. RASHID A, Wang R, Zhang L, Yue J, et al
    Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation.
    Exp Cell Res. 2020 Apr 10:111989. doi: 10.1016/j.yexcr.2020.111989.
    PubMed     Abstract available


  13. LI D, Yu Z, Wang T, Li Y, et al
    The role of the novel LincRNA uc002jit.1 in NF-kB-mediated DNA damage repair in acute myeloid leukemia cells.
    Exp Cell Res. 2020 Apr 4:111985. doi: 10.1016/j.yexcr.2020.111985.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: